l-deprenyl metabolism by the cytochrome P450 system in monkey (Cercopithecus aethiops) liver microsomes

Xenobiotica

Volumn 33, Issue 2, 2003, Pages 181-195

  Dragoni, S ^a   Bellik, L ^a   Frosini, M ^a   Sgaragli, G ^a   Marini, S ^b   Gervasi, P G ^b   Valoti, M ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CYTOCHROME P450; CYTOCHROME P450 1A; KETOCONAZOLE; METHAMPHETAMINE; METHOXSALEN; NORSELEGILINE; SELEGILINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; DEALKYLATION; DRUG METABOLISM; ENZYME INHIBITION; LIVER MICROSOME; MONKEY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE;

ANIMALS; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, GAS; CYTOCHROME P-450 ENZYME SYSTEM; DEALKYLATION; FEMALE; KINETICS; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; MONOAMINE OXIDASE INHIBITORS; SELEGILINE;

ANIMALIA; CERCOCEBUS; CERCOPITHECUS AETHIOPS; PRIMATES;

EID: 0037324318     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/0049825021000048827     Document Type: Article

References (43)

1. AMATO, G., LONGO V., MAZZACARO, A. and GERVASI, P. G., 1998, Chlorzoxazone 6-hydroxylase and p-nitrophenol hydroxylase as the most suitable activities for assaying cytochrome P450 2E1 in cynomolgus monkey liver. Drug Metabolism and Disposition, 26, 483-489.
2. BACH, M. V., COUTTS, R. T. and BAKER, G. B., 2000, Metabolism of N,N-dialkylated amphetamines, including deprenyl, by CYP2D6 expressed in a human cell line. Xenobiotica, 30, 297-306.
3. BAKER, G. B., URICHUK, L. J., MCKENNA, K. F. and KENNEDY, S. H., 1999, Metabolism of monoamine oxidase inhibitors. Cellular and Molecular Neurobiology, 19, 411-426.
4. BIRKMAYER, W., KNOLL, J., RIEDERER, P., YOUDIM, M. D. H., HARS, V. and MARTON, J., 1985, Increased life expectancy resulting from addition of l-deprenyl to Madopar treatment in Parkinson's disease: a long-term study. Journal of Neural Transmission, 64, 113-127.
5. BULLOCK, P., PEARCE, R., DRAPER, A., PODVAL, J., BRACKEN, W., VELTMAN, J., THOMAS, P. and PARKINSON, A., 1995, Induction of liver microsomal cytochrome P450 in cynomolgus monkeys. Drug Metabolism and Disposition, 23, 736-748.
6. DUCHARME, J., ABDULLAH, S. and WAINER, I. W., 1996, Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity. Journal of Chromatography Biomedical Application, 678, 113-128.
7. GERLACH, M., YOUDIM, M. B. and RIEDERER, P., 1996, Pharmacology of selegiline. Neurology, 47 (Suppl. 3), S137-145.
8. GRACE, J. M., KINTER, M. T. and MACDONALD, T. L., 1994, Atypical metabolism of deprenyl and its enantiomer (S)-(+)-N,alpha-dimethyl-N-propynylphenethylamine, by cytochrome P450 2D6. Chemical Research in Toxicology, 7, 286-290.
9. GUENGERICH F. P., GILLAM E. M. and SHIMADA T., 1996, New applications of bacterial systems to problems in toxicology. Critical Review in Toxicology, 26, 551-83.
10. HIDESTRAND, M., OSCARSON, M., SALONEN, J. S., NYMAN, L., PELKONEN, O., TURPEINEN, M. and INGELMAN-SUNDBERG, M., 2001, CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes. Drug Metabolism and Disposition, 29, 1480-1484.
11. JAN, C., FRANCOIS, C., TANDE, D., YELNIK, J., TREMBLAY, L., AGID, Y. and HIRSCH, E., 2000, Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients. European Journal of Neuroscience, 12, 4525-4535.
12. KO, I. Y., PARK, S. S., SONG, B. J., PATTEN, C., TAN, Y. Z., HAH, Y. C., YANG, C. S. and GELBOIN, H. V., 1987, Monoclonal antibodies to ethanol-induced rat liver cytochrome P-450 that metabolizes aniline and nitrosamines. Cancer Research, 47, 3101-3109.
13. KOENIGS, L. L., PETER, R. M., THOMPSON, S. J., RETTIE, A. E. and TRAGER, W. F., 1997, Mechanism-based inactivation of human liver cytochrome P4502A6 by 8-methoxypsoralen. Drug Metabolism and Disposition, 25, 1407-1415.
14. KRIJGSHELD, K. R. and GRAM, T. E., 1984, Selective induction of renal microsomal cytochrome P450-linked monooxygenases by 1,1-dichloroethylene in mice. Biochemical Pharmacology, 33, 1951-1956.
15. 4. Nature, 227, 680-685.
16. LI, Y., LI, N.-Y. and SELLERS, E. M., 1997, Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes. European Journal of Drug Metabolism and Pharmacokinetics, 22, 295-304.
17. LONGO, V., MAZZACARO, A., VENTURA, P. and GERVASI, P. G., 1992, Drug-metabolizing enzymes in respiratory nasal mucosa and liver of cynomolgus monkey. Xenobiotica, 22, 427-431.
18. LOWRY, O., ROSENBROUGH, N., FARR, A. and RANDALL, R., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
19. MÄENPÄÄ, J., SIGUSCH, H., RAUNIO, H., SYNGELMA, T., VUORELA, P., VUORELA, H. and PELKONEN, O. 1993, Differential inhibition of coumarin-7-hydroxylase activity in mouse and human liver microsomes. Biochemical Pharmacology, 45, 1035-1042.
20. MASTERS, B. S. S., WILLIAM, C. H. and KAMIN, H., 1967, The preparation and properties of microsomal NADPH-cytochrome c reductase from pig liver. In R. W. Estabrook and E. E. Pulman (eds), Methods in Enzymology, vol. 10 (New York: Academy Press), pp. 565-573.
21. OHMORI, S., HORIE, T., GUENGERICH, F. P., KIUCHI, M. and KITADA, M., 1993, Purification and characterization of two forms of hepatic microsomal cytochrome P450 from untreated cynomolgus monkeys. Archives of Biochemistry and Biophysics, 305, 405-413.
22. OHTA, K., KITADA, M., HASHIZUME, T., KOMORI M., OHI, H. and KAMATAKI, T., 1989, Purification of cytochrome P450 from polychlorinated biphenyl-treated crab-eating monkeys: high homology to a form of human cytochrome P450. Biochimica et Biophysica Acta, 996, 142-145.
23. OLANOW, C. W. and TATTON, W. G., 1999, Ethiology and pathogenesis of Parkinson's disease. Annual Review of Neuroscience, 22, 123-144.
24. OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370-2378.
25. OTTON, S. V., TYNDALE, R. F., WU, D., INABA T., KALOW W. and SELLERS, E. M., 1992, Catalytic and immunologic similarities between monkey and human liver cytochrome P450db1 (human cytochrome P450 2D6). Drug Metabolism and Disposition, 20, 1-5.
26. PARKINSON, A., 1996, Biotransformation of xenobiotics. In C. D. Klaassen (ed.), Casarett & Doull's Toxicology: The Basic Science of Poisons, 5th edn (New York: McGraw-Hill), pp. 113-186.
27. REINKE, L. A. and MOYER, M. J., 1985, p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metabolism and Disposition, 13, 548-552.
28. SAI, Y., DAI, R., YANG, T. Y. J., KRAUSZ, K. W., GONZALES, F. J., GELBOIN, H. V. and SHOU, M., 2000, Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450. Xenobiotica, 30, 327-343.
29. SCHEININ, H., ANTTILA, M., DAHL, M. L., KARNANI, H., NYMAN, L., TAAVlTSAINEN, P., PELKONEN, O. and BERTILSSON, L., 1998, CYP2D6 polymorphism is not crucial for the disposition of selegiline. Clinical Pharmacology and Therapeutics, 64, 402-411.
30. SHARER, J. E., SHIPLEY, L. A., VANDENBRANDEN, M. R., BINKLEY, N. S. and WRIGHTON, S. A., 1995, Comparison of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cymomolgus monkey. Drug Metabolism and Disposition, 23, 1231-1241.
31. SOUHAILI-EL AMRI, H., BATT, A. M. and SIEST, G., 1986, Comparison of cytochrome P450 content and activities in liver microsomes of seven animal species, including man. Xenobiotica, 16, 351-358.
32. STEVENS, J. C., SHIPLEY, L. A., CASHMAN, J. R., VANDENBRANDEN, M. and WRIGHTON, A. S., 1993, Comparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities. Drug Metabolism and Disposition, 21, 753-760.
33. SZIRAKI, I., KARDOS, V., PATTHY, M., PATFALUSI, M., GAAL, J., SOLTI, M., KOLLAR, E. and SINGER, J., 1994, Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2-methyl-MPTP. Journal of Neural Transmission, 41, 207-219.
34. TAAVITSAINEN, P., ANTTILA, M., NYMAN, L., KARNANI, H., SALONEN, J. S. and PELKONEN, O., 2000, Selegiline metabolism and cytochrome P450 enzymes: in vitro study in human liver microsomes. Pharmacology and Toxicology., 86, 215-221.
35. TATTON, W. G. and GREENWOOD, C. E., 1991, Rescue of dying neurons: a new action for l-deprenyl in MPTP parkinsonism. Journal of Neuroscience Research, 30, 666-672.
36. TAYLOR, J. R., ELSWORTH, J. D., ROTH, R. H., SLADEK, J. R., JR and REDMOND, D. E., JR, 1997, Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus). Neuroscience, 81, 745-755.
37. THE PARKINSON STUDY GROUP, 1993, Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. New England Journal of Medicine, 328, 176-183.
38. TIPTON, K. F., 1994, What is it that l-deprenyl (selegiline) might do? Clinical Pharmacology and Therapeutics, 56, 781-796.
39. TOWBIN, H. T., STAEHELIN, T. and GORDON, J., 1992, Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology, 24, 145-149.
40. TU, Y. Y. and YANG, C. S., 1983, High-affinity nitrosamine dealkylase system in rat liver microsomes and its induction by fasting. Cancer Research, 43, 623-629.
41. VALOTI, M., FUSI, F., FROSINI, M., PESSINA, F., TIPTON, K. F. and SGARAGLI, G. P., 2000, Cytochrome P450-dependent N-dealkylation of l-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, α-naphtoflavone and l-deprenyl. European Journal of Pharmacology, 391, 199-206.
42. WEAVER, R. J., DICKINS, M. and BURKE, M. D., 1999, A comparison of basal and induced hepatic microsomal cytochrome P450 monooxygenase activities in the cynomolgus monkey (Macaca fascicularis) and man. Xenobiotica, 29, 467-482.
43. WEAVER, R. J., THOMPSON, S., SMITH, G., DICKINS, M., ELCOMBE, C. R., MAYERS, R. T. and BURKE, M. D., 1994, A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Biochemical Pharmacology, 47, 763-773.